IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 226-250 out of 1284.

<< < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>

Public Release: 29-Oct-2014
2014 Clinical Congress of the American College of Surgeons
Breast and colorectal cancers remain more aggressive in children
Breast and colorectal cancers rarely occur in children, but when they do, these conditions are more precarious, according to a pair of National Cancer Data Base studies presented this week at the 2014 Clinical Congress of the American College of Surgeons.

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
American College of Surgeons

Public Release: 29-Oct-2014
Nature Communications
Kidney cancer in Central Europe
Large-scale DNA and RNA sequencing of renal cell carcinoma patients in Europe reveals primary causes of kidney cancer vary between populations. Findings provide insights into the genetic architecture of clear-cell renal-cell carcinoma. Association between cancer incidence and exposure to aristolochic acid -- an ingredient in some herbal remedies -- has implications for public health, particularly in Romania.
European Commission Framework Programme 7 (FP7), Genome Quebec, McGill University, Cancer Research UK Centre, ECMC

Contact: Sonia Furtado Neves
pressoffice@embl.de
49-622-138-78263
European Molecular Biology Laboratory

Public Release: 29-Oct-2014
Science Translational Medicine
New molecular imaging technology could improve bladder-cancer detection
Researchers at the Stanford University School of Medicine have developed a new strategy that they say could detect bladder cancer with more accuracy and sensitivity than standard endoscopy methods. Endoscopy refers to a procedure in which surgeons use an instrument equipped with a lens to see inside the patient.

Contact: Krista Conger
kristac@stanford.edu
650-725-5371
Stanford University Medical Center

Public Release: 29-Oct-2014
BJU International
Prostate cancer medications linked with increased risk of heart-related deaths in men with cardiovascular problems
A new study has found that certain prostate cancer medications are linked with an increased risk of dying from heart-related causes in men with congestive heart failure or prior heart attacks. Published in BJU International, the findings will help doctors and patients weigh the benefits and risks of the drugs.

Contact: Evelyn Martinez
sciencenewsroom@wiley.com
201-748-6358
Wiley

Public Release: 29-Oct-2014
JAMA Dermatology
Study examines availability of tanning beds on and near college campuses
Among the top 125 colleges on a list compiled by US News & World Report, 48 percent have indoor tanning facilities either on campus or in off-campus housing despite evidence that tanning is a risk factor for skin cancer, according to a study published online by JAMA Dermatology.

Contact: Lisa M. Larson
lisa.larson@umassmed.edu
508-856-6200
The JAMA Network Journals

Public Release: 29-Oct-2014
Nature
Scientists generate first human stomach tissue in lab with stem cells
Scientists used pluripotent stem cells to generate functional, three-dimensional human stomach tissue in a laboratory -- creating an unprecedented tool for researching the development and diseases of an organ central to several public health crises, ranging from cancer to diabetes. Scientists at Cincinnati Children's Hospital Medical Center report Oct. 29 in Nature they used human pluripotent stem cells -- which can become any cell type in the body -- to grow a miniature version of the stomach.

Contact: Nick Miller
nicholas.miller@cchmc.org
513-803-6035
Cincinnati Children's Hospital Medical Center

Public Release: 28-Oct-2014
Journal of Neuroscience
New findings show that different brain tumors have the same origin
Glioma is a common name for serious brain tumors. Different types of glioma are usually diagnosed as separate diseases and have been considered to arise from different cell types in the brain. Now researchers at Uppsala University have shown that one and the same cell of origin can give rise to different types of glioma. This is important for the basic understanding of how these tumors are formed and can contribute to the development of more efficient and specific glioma therapies.

Contact: Lene Uhrbom
lene.uhrbom@igp.uu.se
46-184-715-063
Uppsala University

Public Release: 28-Oct-2014
Radiology
Screening with tomosynthesis and mammography is cost-effective
Adding tomosynthesis to biennial digital mammography screening for women with dense breasts is likely to improve breast cancer detection at a reasonable cost relative to biennial mammography screening alone, according to a new study.
National Institutes of Health

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America

Public Release: 28-Oct-2014
American Journal of Gastroenterology
IU researchers: Blood test may help to diagnose pancreatic cancer
Indiana University cancer researchers have found that a simple blood test might help diagnose pancreatic cancer, one of the most deadly forms of the disease.
National Institutes of Health

Contact: Michael Schug
maschug@iupui.edu
317-278-0953
Indiana University

Public Release: 28-Oct-2014
Cancer
Radiation exposure linked to aggressive thyroid cancers
For the first time, researchers have found that exposure to radioactive iodine is associated with more aggressive forms of thyroid cancer, according to a careful study of nearly 12,000 people in Belarus who were exposed when they were children or adolescents to fallout from the 1986 Chernobyl nuclear power plant accident.

Contact: Laura Kurtzman
laura.kurtzman@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 28-Oct-2014
American Journal of Clinical Nutrition
Tea and citrus products could lower ovarian cancer risk, new UEA research finds
Tea and citrus fruits and juices are associated with a lower risk of developing ovarian cancer, according to new research from the University of East Anglia. The team found that those who consumed food and drinks high in flavonols -- found in tea, red wine, apples and grapes -- and flavanones -- found in citrus fruit and juices -- were less likely to develop the disease.

Contact: Laura Potts
laura.potts@uea.ac.uk
44-016-035-93007
University of East Anglia

Public Release: 28-Oct-2014
Science Signaling
Modeling cancer: Virginia Tech researchers prove models can predict cellular processes
Researchers developed mathematical models to predict the dynamics of cell transitions, and compared their results with actual measurements of activity in cell populations. The results could inform efforts to treat cancer patients.

Contact: Lindsay Taylor Key
ltkey@vt.edu
540-231-6594
Virginia Tech

Public Release: 28-Oct-2014
Annals of Oncology
European consensus on methodological recommendations for clinical studies in rare cancers
One out of every five new cancer patients is diagnosed with a rare cancer, yet the clinical evidence needed to effectively treat these rare cancer patients is scarce. Rare cancers require alternative ways to conceive study designs and to analyze data.

Contact: John Bean
john.bean@eortc.be
European Organisation for Research and Treatment of Cancer

Public Release: 28-Oct-2014
Journal of Clinical Investigation
CHORI scientists identify key factor in relationship between diet, inflammation and cancer
A team of Children's Hospital and Research Center Oakland researchers has found that a category of lipids known as sphingolipids may be an important link in the relationship between diet, inflammation and cancer.
Chidlren's Hospital Oakland Research Institute

Contact: Melinda Krigel
mkrigel@mail.cho.org
510-428-3069
Children's Hospital & Research Center Oakland

Public Release: 28-Oct-2014
Cancer Research
Improving breast cancer chemo by testing patient's tumors in a dish
A team of biomedical engineers have developed a technique that monitors the response of 3-D chunks of a patient's tumor to determine how effective different anti-cancer drugs will be before starting chemotherapy.

Contact: David Salisbury
david.salisbury@vanderbilt.edu
615-343-6803
Vanderbilt University

Public Release: 27-Oct-2014
2014 Clinical Congress of the American College of Surgeons
Most Internet sources on prostate cancer disagree with expert panel's recommendation
Only 17 percent of top-ranked consumer health websites advise against screening for prostate cancer, a recommendation made more than two years ago by the U.S. Preventive Services Task Force, according to a study presented at the 2014 Clinical Congress of the American College of Surgeons.

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
American College of Surgeons

Public Release: 27-Oct-2014
Nature Communications
How cells know which way to go
Amoebas aren't the only cells that crawl: Movement is crucial to development, wound healing and immune response in animals, not to mention cancer metastasis. In two new studies from Johns Hopkins, researchers answer long-standing questions about how complex cells sense the chemical trails that show them where to go -- and the role of cells' internal 'skeleton' in responding to those cues.
NIH/National Institute of General Medical Sciences, National Natural Science Foundation of China, Damon Runyon Cancer Research Foundation

Contact: Shawna Williams
shawna@jhmi.edu
410-955-8236
Johns Hopkins Medicine

Public Release: 27-Oct-2014
Journal of the National Cancer Institute
Higher copayments are associated with discontinuation of aromatase inhibitors
Discontinuation and nonadherence were higher among breast cancer patients taking brand name aromatase inhibitors vs. generic AIs, according to a new study published Oct. 27 in the JNCI: Journal of the National Cancer Institute.

Contact: Zachary Rathner
Zachary.Rathner@oup.com
919-677-2697
Oxford University Press USA

Public Release: 27-Oct-2014
Cancer
Chest radiation to treat childhood cancer increases patients' risk of breast cancer
A new study has found that patients who received chest radiation for Wilms tumor, a rare childhood cancer, face an increased risk of developing breast cancer later in life due to their radiation exposure.

Contact: Evelyn Martinez
sciencenewsroom@wiley.com
Wiley

Public Release: 27-Oct-2014
Canadian Medical Association Journal
New prostate cancer screening guideline recommends not using PSA test
A new Canadian guideline recommends that the prostate-specific antigen (PSA) test should not be used to screen for prostate cancer based on evidence that shows an increased risk of harm and uncertain benefits. The guideline is published in CMAJ.

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116
Canadian Medical Association Journal

Public Release: 27-Oct-2014
Analytical Methods
Prostate cancer, kidney disease detected in urine samples on the spot
New device screens for kidney disease, prostate cancer on the spot. The tiny tube is lined with DNA sequences that latch onto disease markers in urine. While healthy samples flow freely, a diseased sample gets clogged and stops short of the mark.
National Institutes of Health

Contact: Joe Hadfield
joe_hadfield@byu.edu
801-422-9206
Brigham Young University

Public Release: 27-Oct-2014
Journal of National Cancer Institute
Generic medications boost adherence to breast cancer therapy
A study has found that the introduction of generic breast cancer drugs, which are less expensive than their brand-name counterparts, increased treatment adherence by 50 percent.
American Cancer Society

Contact: Karin Eskenazi
ket2116@columbia.edu
212-342-0508
Columbia University Medical Center

Public Release: 27-Oct-2014
Cancer Research
Delivering a 1-2 punch: New drug combination shows promise in treating breast cancer
The uncontrolled growth of cancer cells arises from their ability to hijack the cell's normal growth program and checkpoints. Usually after therapy, a second cancer-signaling pathway opens after the primary one shuts down -- creating an escape route for the cancer cell to survive. The answer, say Case Western Reserve researchers, is to anticipate and block that back-up track by prescribing two drugs. The results of the project appeared this fall in the journal Cancer Research.
National Institutes of Health

Contact: Jeannette Spalding
jeannette.spalding@case.edu
216-368-3004
Case Western Reserve University

Public Release: 27-Oct-2014
Cancer Epidemiology
Prostate cancer risk reduced by sleeping with many women, but increased with many men
Compared to men who have had only one partner during their lifetime, having sex with more than 20 women is associated with a 28 percent lower risk of one day being diagnosed with prostate cancer. However, having more than 20 male partners in one's lifetime is associated with a twofold higher risk of getting prostate cancer compared to those who have never slept with a man.
Canadian Cancer Society, Cancer Research Society, Fonds de recherche du Québec—Santé, Ministère du Développement économique, de l'Innovation et de l'Exportation du Québec

Contact: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-566-3813
University of Montreal

Public Release: 27-Oct-2014
Cancer Research
Study may explain why targeted drug doesn't benefit patients with early-stage lung cancer
The drug erlotinib is highly effective in treating advanced-stage lung cancer patients whose tumors have a particular gene mutation, but when the same drug is used for patients with early-stage tumors with the same gene change, they fare worse than if they took nothing. This study might explain why.
NIH/National Cancer Institute

Contact: Eileen Scahill
Eileen.Scahill@osumc.edu
614-293-3737
Ohio State University Wexner Medical Center

Showing releases 226-250 out of 1284.

<< < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>

  Search News Releases

     

 

EurekAlert!